5-Bromo-2-Chloropyrimidine CAS 32779-36-5 Purity ≥99.5% (HPLC) Macitentan Intermediate Factory

Lus piav qhia luv luv:

Lub npe tshuaj: 5-Bromo-2-Chloropyrimidine

CAS: 32779-36-5 Nr

Purity: ≥99.5% (HPLC)

Cov tsos mob: Dawb rau Off-White hmoov

Intermediate of Macitentan (CAS: 441798-33-0) rau kev kho mob Pulmonary Arterial Hypertension (PAH)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chaw tsim tshuaj paus Commercial Supply Macitentan Related Intermediates
5-(4-Bromophenyl)-4,6-Dichloropyrimidine CAS 146533-41-7
5-Bromo-2-Chloropyrimidine CAS 32779-36-5

Chemical Properties:

Tshuaj npe 5-Bromo-2-Chloropyrimidine
Synonyms 2-Chloro-5-Bromopyrimidine;Macitentan Intermediate 5
CAS Nr 32779-36-5
CAT Number Qauv: RF-PI854
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C4H2BrClN2
Molecular Luj 193.43 Nws
Melting Point 73.0 ~ 79.0 ℃ (lit.)
Boiling Point 95 ℃ / 15 mmHg
Solubility Soluble hauv Methanol;Insoluble hauv dej
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Dawb rau Off-White Powder
Kev txheeb xyuas IR/HPLC
Purity / Analysis Method ≥99.5% (HPLC)
Moisture (KF) ≤0.50%
Residue ntawm Ignition ≤ 0.20%
Ib leeg Impurity ≤ 0.30%
Tag nrho cov impurities ≤0.50%
Test Standard Enterprise Standard
Kev siv Pharmaceutical Intermediates;Macitentan Intermediate

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

1

FAQ:

Daim ntawv thov:

5-Bromo-2-Chloropyrimidine (CAS: 32779-36-5) yog siv los ua tshuaj nruab nrab, hauv kev sib xyaw ntawm Cov Khoom Siv Tshuaj (APIs).Nws kuj tseem ua haujlwm nyob rau hauv kev sib txuas sib txuas ntawm indium organometallics nrog 2,5-Dihalopyrimidines.5-Bromo-2-Chloropyrimidine yog qhov nruab nrab ntawm Macitentan (CAS: 441798-33-0).Macitentan tau txais kev pom zoo los ntawm US FDA thaum Lub Kaum Hli 2013 rau kev kho mob pulmonary arterial hypertension (PAH) (WHO pawg I) kom ncua kev kis kab mob.

Sau koj cov lus ntawm no thiab xa tuaj rau peb